VIVO
Fuller & Thaler Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-524,904
| Closed | -$17.4M | – | 556 |
|
2022
Q4 | $17.4M | Sell |
524,904
-12,916
| -2% | -$429K | 0.11% | 168 |
|
2022
Q3 | $17M | Sell |
537,820
-5,449
| -1% | -$172K | 0.12% | 169 |
|
2022
Q2 | $16.5M | Buy |
543,269
+84,492
| +18% | +$2.57M | 0.11% | 175 |
|
2022
Q1 | $11.9M | Buy |
458,777
+3,112
| +0.7% | +$80.8K | 0.07% | 214 |
|
2021
Q4 | $9.3M | Buy |
455,665
+256,729
| +129% | +$5.24M | 0.05% | 241 |
|
2021
Q3 | $3.83M | Sell |
198,936
-1,496,815
| -88% | -$28.8M | 0.02% | 274 |
|
2021
Q2 | $37.6M | Buy |
1,695,751
+54,351
| +3% | +$1.21M | 0.24% | 122 |
|
2021
Q1 | $43.1M | Buy |
1,641,400
+60,583
| +4% | +$1.59M | 0.3% | 106 |
|
2020
Q4 | $29.5M | Buy |
1,580,817
+387,466
| +32% | +$7.24M | 0.27% | 112 |
|
2020
Q3 | $20.3M | Buy |
1,193,351
+92,288
| +8% | +$1.57M | 0.26% | 112 |
|
2020
Q2 | $25.6M | Buy |
1,101,063
+1,099,413
| +66,631% | +$25.6M | 0.34% | 91 |
|
2020
Q1 | $14K | Hold |
1,650
| – | – | ﹤0.01% | 454 |
|
2019
Q4 | $16K | Hold |
1,650
| – | – | ﹤0.01% | 447 |
|
2019
Q3 | $16K | Hold |
1,650
| – | – | ﹤0.01% | 452 |
|
2019
Q2 | $20K | Hold |
1,650
| – | – | ﹤0.01% | 427 |
|
2019
Q1 | $29K | Hold |
1,650
| – | – | ﹤0.01% | 397 |
|
2018
Q4 | $29K | Hold |
1,650
| – | – | ﹤0.01% | 391 |
|
2018
Q3 | $25K | Hold |
1,650
| – | – | ﹤0.01% | 392 |
|
2018
Q2 | $26K | Hold |
1,650
| – | – | ﹤0.01% | 715 |
|
2018
Q1 | $23K | Hold |
1,650
| – | – | ﹤0.01% | 716 |
|
2017
Q4 | $23K | Buy |
1,650
+600
| +57% | +$8.36K | ﹤0.01% | 688 |
|
2017
Q3 | $15K | Hold |
1,050
| – | – | ﹤0.01% | 660 |
|
2017
Q2 | $17K | Hold |
1,050
| – | – | ﹤0.01% | 657 |
|
2017
Q1 | $14K | Hold |
1,050
| – | – | ﹤0.01% | 680 |
|
2016
Q4 | $19K | Hold |
1,050
| – | – | ﹤0.01% | 690 |
|
2016
Q3 | $20K | Buy |
+1,050
| New | +$20K | ﹤0.01% | 706 |
|